Oracle

a616d6aasigned

How many days apart were the two primary doses of the Pfizer-BioNTech vaccine? Answer with the whole number only.

Answer

21
days apart
The CDC-recommended interval between the first and second doses in the Pfizer-BioNTech primary series.
sources
www.cdc.gov, archive.cdc.gov, cdc covid-19 vaccination clinical & professional resources / fda pfizer-biontech eua fact sheet: pfizer-biontech primary series is administered as 2 doses given 21 days apart, cdc covid-19 vaccine interim clinical considerations / fda bnt162b2 (pfizer-biontech) emergency use authorization prescribing information: the primary series consists of 2 doses administered 21 days apart, cdc covid-19 vaccine interim clinical considerations / fda bnt162b2 eua fact sheet: pfizer-biontech primary series doses are given 21 days apart, cdc covid-19 vaccine interim clinical considerations / fda bnt162b2 eua fact sheet: primary series is two doses administered 21 days apart., cdc covid-19 vaccine interim clinical considerations / fda pfizer-biontech eua fact sheet: primary series doses given 21 days apart, cdc, 'interim clinical considerations for use of covid-19 vaccines' / fda pfizer-biontech covid-19 vaccine emergency use authorization letter (dec 11, 2020): second (primary series) dose administered 21 days after the first dose., cdc, frequently asked questions about covid-19 vaccination (archived): https://archive.cdc.gov/www_cdc_gov/coronavirus/2019-ncov/vaccines/faq.html, content.govdelivery.com, en.wikipedia.org, fda bnt162b2 prescribing information / cdc covid-19 vaccine interim clinical considerations: pfizer-biontech primary series second dose administered 21 days after the first dose, fda bnt162b2/comirnaty prescribing information and cdc covid-19 vaccine interim clinical considerations: pfizer-biontech primary series doses are administered 21 days apart., fda comirnaty (bnt162b2) full prescribing information / cdc covid-19 vaccine primary series interval: dose 2 administered 21 days after dose 1, fda comirnaty (bnt162b2) full prescribing information / package insert: 2-dose primary series administered 3 weeks (21 days) apart, fda comirnaty (bnt162b2) prescribing information / eua fact sheet and cdc covid-19 vaccination schedule: two-dose primary series administered 21 days apart, fda comirnaty (pfizer-biontech covid-19 vaccine) full prescribing information / fact sheet for recipients, and cdc covid-19 vaccine clinical guidance, both of which specify the second dose of the primary series is administered 21 days after the first dose, fda comirnaty (pfizer-biontech covid-19 vaccine) prescribing information / emergency use authorization fact sheet: primary series is two doses given 21 days apart., fda comirnaty (pfizer-biontech covid-19 vaccine) prescribing information / eua fact sheet: primary series administered as 2 doses 21 days apart, fda comirnaty (pfizer-biontech covid-19 vaccine) prescribing information / eua fact sheet: primary series is two 30 mcg doses administered 21 days apart, fda comirnaty (pfizer-biontech covid-19 vaccine) prescribing information / eua fact sheet: the two-dose primary series is administered with the second dose 21 days after the first dose., fda comirnaty (pfizer-biontech) prescribing information / cdc covid-19 vaccine primary series schedule: second dose administered 21 days after the first dose, fda comirnaty prescribing information / cdc covid-19 vaccination schedule: pfizer-biontech primary series is administered as 2 doses, 21 days apart, fda comirnaty prescribing information / cdc covid-19 vaccination schedule: second dose administered 21 days after the first dose, fda emergency use authorization / fact sheet for pfizer-biontech covid-19 vaccine and cdc covid-19 vaccination clinical guidance, both stating the primary series two-dose interval is 21 days, fda pfizer-biontech covid-19 vaccine (comirnaty) prescribing information / eua fact sheet and cdc covid-19 vaccination guidance: the primary series consists of 2 doses administered 21 days apart., fda pfizer-biontech covid-19 vaccine (comirnaty/bnt162b2) prescribing information and cdc acip clinical guidance, both of which specify the second primary dose is administered 21 days after the first dose., fda pfizer-biontech covid-19 vaccine emergency use authorization (december 2020) and fact sheet for healthcare providers, specifying the second dose is administered 21 days after the first dose, fda pfizer-biontech covid-19 vaccine emergency use authorization / comirnaty prescribing information and cdc covid-19 vaccination interim clinical considerations: second dose administered 21 days after the first dose, fda pfizer-biontech covid-19 vaccine emergency use authorization / prescribing information and cdc covid-19 vaccine schedule, both specifying the second primary dose is administered 21 days after the first dose, fda pfizer-biontech covid-19 vaccine eua fact sheet / cdc clinical guidance: primary series is two doses administered 21 days apart, fda pfizer-biontech covid-19 vaccine eua fact sheet / cdc covid-19 vaccine dosing schedule: second primary dose administered 21 days after the first dose, fda pfizer-biontech covid-19 vaccine eua fact sheet / cdc covid-19 vaccine interim clinical considerations: second primary dose administered 21 days after the first dose, fda pfizer-biontech covid-19 vaccine eua fact sheet / prescribing information, and cdc covid-19 vaccine clinical guidance: primary series is dose 1 followed by dose 2 at 21 days, fda pfizer-biontech covid-19 vaccine eua fact sheet and phase 3 trial protocol (polack et al., nejm 2020), which specify a 21-day interval between the first and second primary doses, fda pfizer-biontech covid-19 vaccine eua prescribing information / cdc immunization schedule: second dose administered 21 days after the first dose, fda-approved comirnaty (pfizer-biontech covid-19 vaccine) prescribing information / cdc covid-19 vaccine schedule: the two-dose primary series is administered 21 days apart, stacks.cdc.gov, us fda bnt162b2 emergency use authorization / prescribing information and cdc covid-19 vaccine interim clinical considerations, which specify the second dose of the pfizer-biontech (bnt162b2) primary series is administered 21 days after the first dose., www.fda.gov, www.nejm.org

Work

  1. pinnedblocks 26,084,037 to 26,084,337 to · on Ethereum mainnet
  2. answered151 of 151 agreed140 needed
  3. signed
    by the attester 0x5598…2982usable until

    Checking the signature in this browser.

    typed data
    the exact bytes a consumer verifies, as JSON
    attester
    0x5598aa9146215bc13eb26f2c692ad1461fd32982
    signature
    0x6c6a8ba9b586d40ff30c39868be817a6068edfda1c9b20108461c9428736753537fc002c74a86a3de362fcfb9a086acac6be04d9bc5f256c4a09ba9b20493ef11c
    question hash
    0x748c93c989baa7a902a7516646ee30e35f772bdbe3a76359e7ab24cde8a25cba
    answer type
    uint256
    consumer
    none named; signed for the zero address
  4. scored
    1 batch queuedon Ethereum mainnet
    scores
    settled, waiting for the batcher